Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients

被引：15
|
作者：
Colak, T [1 ]
Karakayali, H [1 ]
Yagmurdur, MC [1 ]
Moray, G [1 ]
机构：
[1] Baskent Univ, Fac Med, TR-06490 Ankara, Turkey
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(02)02859-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2081 / 2082
页数：2
相关论文
共 50 条
  • [41] METABOLIC EFFECTS OF CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE IN RENAL-TRANSPLANT RECIPIENTS
    HARRIS, KPG
    RUSSELL, GI
    PARVIN, SP
    VEITCH, PS
    WALLS, J
    PROCEEDINGS OF THE EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION, 1985, 21 : 1010 - 1014
  • [42] Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients
    van den Dorpel, MA
    Levi, M
    Ijzermans, JN
    ten Cate, JW
    Weimar, W
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 329 - 329
  • [43] Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients
    van den Dorpel, MA
    Man in't Veld, AJ
    Levi, M
    ten Cate, JW
    Weimar, W
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) : 1555 - 1558
  • [44] Dose Conversion Factor Between Cyclosporine and Tacrolimus in Pediatric Heart Transplant Recipients
    Notaro, E.
    Brown, L.
    Albers, E.
    Law, S.
    Law, Y.
    Kemna, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 235 - 235
  • [45] Conversion of tacrolimus for cyclosporine-associated toxicities in allogeneic transplant recipients.
    Meyer, D
    Vindelow, L
    Sengelov, H
    BLOOD, 2003, 102 (11) : 719A - 719A
  • [46] Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients
    Notaro, Eliza
    Brown, Lisa
    Albers, Erin
    Law, Sabrina
    Kemna, Mariska
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (07): : 766 - 768
  • [47] Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients
    Israni, A
    Brozena, S
    Pankewycz, O
    Grossman, R
    Bloom, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03)
  • [48] Effect of conversion from cyclosporine A (CSA) to tacrolimus (FK 506) on cardiovascular risk factors in liver transplant recipients.
    Canzanello, VJ
    Schwartz, LL
    Taler, SJ
    Textor, SC
    Atwood, G
    Porayko, MK
    Wiesner, RH
    Krom, RAF
    HEPATOLOGY, 1997, 26 (04) : 1443 - 1443
  • [49] Effect of Conversion from Tacrolimus to Cyclosporine on BK Viremia among Kidney Transplant Recipients: The TACCsA-SWITCH Study
    Ali, Shaikha Rashid
    Png, Hon Shen
    AlGhamdi, A. Abdullah Ashour
    Gangji, Azim S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [50] Conversion from Tacrolimus IR (Twice Daily) or Cyclosporine to Tacrolimus XR (Envarsus®, Once Daily) in Lung Transplant Recipients
    McMurry, K. A.
    Fitzgerald, L. J.
    Lyu, D. M.
    Chan, K. M.
    Jia, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S505 - S505
12345